infectious disease

FDA approvals, pharma deals, and genetic testing advancements led the news this week.

Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly. 

Trinity College Dublin researchers report a nasal vaccine that prevented infection and spread of pertussis in preclinical models.

Strategies including parasite-based vaccines, mosquito-transmission blockers, and antibody drugs are promising new ways to target the disease.  

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.

A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility. 

Merck researchers developed an effective vaccine against pneumococcal diseases.

Organic molecules with novel biological properties offer new ways to eliminate multidrug-resistant bacteria. 

New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.

Scientists weaponize the symbiotic bacteria in mosquitoes against the deadly diseases they transmit.